Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " July 20, 2011":" August 19, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine
Condition: HIV Infections
Interventions: Biological: DNA HIVIS and MVA-CMDR;   Biological: Saline solution
2 Recruiting the ANRS CO21 " Extreme " Cohort (CODEX)
Condition: HIV Infection
Intervention: Biological: blood sampling
3 Completed Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
Condition: HIV-infection
Intervention: Drug: Angiotensin II Infusion
4 Active, not recruiting Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Condition: HIV-infection/Aids
Intervention: Behavioral: Health Navigator
5 Completed Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
Condition: HIV-Infection
Intervention: Other: Time of starting antiretroviral therapy
6 Unknown  Depression and ART Adherence in HIV+ Latinos
Conditions: Depressive Symptoms;   HIV Infections
Intervention: Behavioral: Cognitive-Behavioral Therapy AD
7 Completed Centralized Off-Site Adherence Enhancement Program
Condition: HIV/AIDS, Medication Adherence
Intervention: Behavioral: cognitive-behavioral therapy
8 Terminated Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
Conditions: Human Immunodeficiency Virus;   Lipohypertrophy
Intervention: Drug: Raltegravir-Maraviroc
9 Terminated Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Experimental: Empiric TB treatment;   Drug: ART only arm
10 Unknown  HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
Conditions: HIV;   Drug Use Disorders
Interventions: Behavioral: HEART to HAART;   Behavioral: adherence counseling with the addition of smartphone control
11 Completed A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
Condition: Human Immunodeficiency Virus
Intervention: Drug: P2G12
12 Completed Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Condition: HIV
Intervention: Dietary Supplement: Moringa oleifera
13 Completed
Has Results
Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi
Condition: HIV
Interventions: Other: Home assessment and initiation of ART;   Other: Clinic-based ART assessment and initiation
14 Active, not recruiting Eplerenone in HIV Associated Abdominal Fat Accumulation
Condition: HIV
Interventions: Drug: Eplerenone and lifestyle;   Other: placebo and lifestyle
15 Completed
Has Results
Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects
Condition: HIV
Interventions: Drug: Atazanavir (current formulation);   Drug: Atazanavir, powder for oral use 1 (POU1);   Drug: Atazanavir (POU2)
16 Completed Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
Condition: HIV Prevention
Interventions: Behavioral: Integrated treatment program;   Behavioral: Treatment as Usual
17 Completed Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel;   Drug: Depo-medroxyprogesterone acetate (DMPA);   Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
18 Active, not recruiting Adolescent Master Protocol
Condition: HIV/AIDS
Intervention:
19 Completed Drug Interaction Study Between Dolutegravir and Prednisone
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir;   Drug: Prednisone
20 Active, not recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.